Evidence map›Paper›PMID 36225370›Full record

ArticleFrontiers in microbiology2022

Identification and characterization of a novel metallo β-lactamase, SZM-1, in Shenzhen Bay, South China.

Lingxu Fang, Zongbao Liu, Zhongyi Lu, Rongzhong Huang, Rong Xiang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lingxu FangDepartment of Stomatology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, China.
Zongbao LiuKey Laboratory of Ecology of Rare and Endangered Species and Environmental Protection, College of Life Sciences, Guangxi Normal University, Guilin, China.
Zhongyi LuArchaeal Biology Center, Institute for Advanced Study, Shenzhen University, Shenzhen, China.
Rongzhong HuangPrecision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Rong XiangPrecision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metallo β-Lactamases (MBLs) degrade most clinical β-lactam antibiotics, especially Carbapenem, posing a huge threat to global health. Studies on environmental MBLs are important for risk assessment of the MBLs transmission among connected habitats, and between environment and human. Here, we described a novel metallo β-Lactamases, named SZM-1 (Shenzhen metallo-β-lactamase), from an

Indexed as

carbapenemasecarbapenem-resistancemetagenomic sequencingmetallo β-lactamaseSZM-1

Identifiers

PMID36225370
PMCPMC9549060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.